- Home
- CAC vs AXGN Comparison
CAC vs AXGN Comparison
Compare CAC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- AXGN
- Stock Information
- Founded
- CAC 1875
- AXGN N/A
- Country
- CAC United States
- AXGN United States
- Employees
- CAC N/A
- AXGN N/A
- Industry
- CAC Major Banks
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CAC Finance
- AXGN Health Care
- Exchange
- CAC Nasdaq
- AXGN Nasdaq
- Market Cap
- CAC 688.3M
- AXGN 577.0M
- IPO Year
- CAC 1997
- AXGN N/A
- Fundamental
- Price
- CAC $39.82
- AXGN $16.82
- Analyst Decision
- CAC Buy
- AXGN Strong Buy
- Analyst Count
- CAC 3
- AXGN 5
- Target Price
- CAC $48.00
- AXGN $26.00
- AVG Volume (30 Days)
- CAC 56.5K
- AXGN 1.1M
- Earning Date
- CAC 10-28-2025
- AXGN 11-06-2025
- Dividend Yield
- CAC 4.22%
- AXGN N/A
- EPS Growth
- CAC 4.80
- AXGN N/A
- EPS
- CAC 3.11
- AXGN N/A
- Revenue
- CAC $197,501,000.00
- AXGN $203,271,000.00
- Revenue This Year
- CAC $42.11
- AXGN $19.65
- Revenue Next Year
- CAC $5.51
- AXGN $15.84
- P/E Ratio
- CAC $12.78
- AXGN N/A
- Revenue Growth
- CAC 21.74
- AXGN 17.17
- 52 Week Low
- CAC $34.53
- AXGN $9.22
- 52 Week High
- CAC $50.07
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- CAC 47.61
- AXGN 63.97
- Support Level
- CAC $39.82
- AXGN $16.11
- Resistance Level
- CAC $40.75
- AXGN $17.00
- Average True Range (ATR)
- CAC 0.84
- AXGN 0.57
- MACD
- CAC -0.08
- AXGN -0.03
- Stochastic Oscillator
- CAC 16.49
- AXGN 84.04
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.